July 31, 2014
The MPN Research Foundation has joined forces with a coalition of patient advocacy organizations who seek to reduce the disparity in copays for people on specialty medication. The initiative, called Cap the Copay, is working to fix what we see as a disparately high copay for people who must take specialty tier medication (such as Jakafi and Pegasys) to manage their illness. We have heard from MPN patients in Illinois that this is an important issue to them, and we are proud to be a part of this larger effort by groups such as NORD, LL&S and American Cancer Society.
This is part of a larger effort to expand our work in policy initiatives that have a meangingful impact on MPN patients, researchers and physicians.